Cargando…
Recurrence of methotrexate-induced leukoencephalopathy after methotrexate rechallenge: A case report and literature review
Methotrexate (MTX) is potent chemotherapeutic agent, often administered intrathecally to treat or prevent central nervous system involvement in lymphomas and leukemias, particularly T-cell lymphoblastic leukemia (T-LBL). MTX has been linked to adverse neurologic effects that mimic acute stroke, incl...
Autores principales: | AlKawi, Ammar, Hanbali, Amr, Haj Aissa, Naser, Mufti, Mohammad Alaa, Abdul Rab, Saleha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9793162/ https://www.ncbi.nlm.nih.gov/pubmed/36582751 http://dx.doi.org/10.1016/j.radcr.2022.11.057 |
Ejemplares similares
-
Methotrexate: Leukoencephalopathy: case report
Publicado: (2021) -
Methotrexate‐induced leukoencephalopathy presenting as stroke in the emergency department
por: Cruz‐Carreras, Maria Teresa, et al.
Publicado: (2017) -
Toxic leukoencephalopathy with axonal spheroids caused by chemotherapeutic drugs other than methotrexate
por: Lim, Ka Young, et al.
Publicado: (2022) -
Conjoint glutamic acid decarboxylase 65 and P/Q voltage gated calcium channel antibodies in autoimmune epilepsy: A case report
por: AlKhaja, Mohamed, et al.
Publicado: (2017) -
Simultaneous Development of Progressive Multifocal Leukoencephalopathy and Cryptococcal Meningitis during Methotrexate and Infliximab Treatment
por: Nosaki, Yasunobu, et al.
Publicado: (2019)